Indo-Bangla Pharmaceuticals Limited (DSE: IBP)
Bangladesh
· Delayed Price · Currency is BDT 9.00
-0.10 (-1.10%)
At close: Nov 14, 2024
IBP Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jul '22 Jul 1, 2022 | Jul '21 Jul 1, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2015 |
| Net Income | -18.08 | 8.41 | 25.17 | 134.73 | 156.24 | 155.23 | Upgrade
|
| Depreciation & Amortization | 38.36 | 38.36 | 39.13 | 35.9 | 28.9 | 21.97 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.7 | -0.7 | - | 0.77 | - | 4.19 | Upgrade
|
| Other Operating Activities | 56.52 | 14.57 | -1.54 | 7.69 | 25.11 | 0.26 | Upgrade
|
| Change in Accounts Receivable | -4.72 | -4.72 | 26.82 | -19.67 | -46.04 | 8.25 | Upgrade
|
| Change in Inventory | 2.47 | 2.47 | 21.01 | -11.8 | 12.58 | -36.11 | Upgrade
|
| Change in Accounts Payable | -0.09 | -0.09 | 0.31 | 0.25 | -5.74 | -0.43 | Upgrade
|
| Change in Other Net Operating Assets | 14.65 | 14.65 | -23.61 | 3.17 | 4.47 | 13.44 | Upgrade
|
| Operating Cash Flow | 88.41 | 72.95 | 87.28 | 151.02 | 175.53 | 166.79 | Upgrade
|
| Operating Cash Flow Growth | 153.68% | -16.42% | -42.20% | -13.96% | 5.24% | 90.72% | Upgrade
|
| Capital Expenditures | -13.48 | -30.03 | -39.68 | -200.41 | -309 | -181.99 | Upgrade
|
| Investing Cash Flow | -29.62 | -43.47 | -54.18 | -200.41 | -309 | -281.99 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 84.94 | - | - | Upgrade
|
| Total Debt Issued | -12.65 | - | - | 84.94 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -31.75 | -9.59 | - | - | - | Upgrade
|
| Total Debt Repaid | -40.35 | -31.75 | -9.59 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -53 | -31.75 | -9.59 | 84.94 | - | - | Upgrade
|
| Issuance of Common Stock | - | - | - | - | - | 200 | Upgrade
|
| Common Dividends Paid | -2.21 | -10.4 | -24.79 | -26.91 | -13.27 | - | Upgrade
|
| Other Financing Activities | -5.07 | -4.72 | -5.63 | - | - | -15.9 | Upgrade
|
| Financing Cash Flow | -60.28 | -46.87 | -40 | 58.03 | -13.27 | 184.1 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | -0 | 0 | 13.11 | - | - | Upgrade
|
| Net Cash Flow | -1.49 | -17.39 | -6.9 | 21.75 | -146.74 | 68.9 | Upgrade
|
| Free Cash Flow | 74.93 | 42.92 | 47.6 | -49.39 | -133.47 | -15.2 | Upgrade
|
| Free Cash Flow Growth | - | -9.84% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 35.41% | 11.46% | 9.82% | -6.31% | -15.41% | -2.05% | Upgrade
|
| Free Cash Flow Per Share | 0.67 | 0.37 | 0.41 | -0.43 | -1.17 | -0.15 | Upgrade
|
| Cash Interest Paid | 5.07 | 4.72 | 5.63 | - | - | - | Upgrade
|
| Cash Income Tax Paid | - | 6.32 | 13.72 | 16.35 | 35.65 | 25.29 | Upgrade
|
| Levered Free Cash Flow | 50.48 | 15.65 | 75.07 | -74.57 | -157.1 | -158.87 | Upgrade
|
| Unlevered Free Cash Flow | 53.05 | 18.92 | 78.12 | -72.19 | -157.1 | -158.87 | Upgrade
|
| Change in Net Working Capital | -29.65 | 7.34 | -56.3 | 15.99 | 9.39 | 104.63 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.